Home Page
BEIJING--June 8, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--China has authorized five companies for COVID-19 vaccine production: Sinopharm Beijing Institute, SinoVac, CanSinoBIO, Sinopharm Wuhan Institute and Anhui Zhifei Longcom. Industrial Info is tracking five active COVID-19 vaccine projects, worth $698 million in China, two of which will kick off in the second half of this year.
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×Contact Us
For More Info!
